Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2018, Article ID 3458439, 6 pages
https://doi.org/10.1155/2018/3458439
Research Article

Polymorphisms in the Osteopontin Are Associated with Susceptibility to Ankylosing Spondylitis in a Han Chinese Population

1Department of Pharmacy, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
2Department of Pain, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
3Department of Endocrinology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
4Department of Information, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

Correspondence should be addressed to Aiping Deng; moc.361@bxypad and Guoliang Yang; moc.qq@4977565261

Received 26 October 2017; Accepted 20 December 2017; Published 18 January 2018

Academic Editor: Ewa Mojs

Copyright © 2018 Juyi Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Castro-Santos, M. A. Gutiérrez, and R. Díaz-Peña, “Genética, HLA-B27 y espondilitis anquilosante: 40 años,” Revista Médica de Chile, vol. 142, no. 9, pp. 1165–1173, 2014. View at Publisher · View at Google Scholar
  2. B. Xu, J.-X. Ma, X.-L. Ma, H.-B. Jia, R. Feng, and L.-Y. Xu, “Association between rs7517847 and rs2201841 polymorphisms in IL-23 receptor gene and risk of ankylosing spondylitis: A meta-analysis,” PeerJ, vol. 2015, no. 3, article no. e910, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. N. Haroon and R. D. Inman, “Ankylosing spondylitis - new criteria, new treatments,” Bulletin of the NYU Hospital for Joint Diseases, vol. 68, pp. 171–174, 2010. View at Google Scholar
  4. Q. Zeng, R. Chen, J. Darmawan et al., “Rheumatic diseases in China,” Arthritis Research & Therapy, vol. 10, no. 1, p. R17, 2008. View at Publisher · View at Google Scholar
  5. N. G. Wang, F. Wang, B. Y. Tan, S. J. Han, J. Dong, Z. N. Yuan et al., “Genetic analysis of Tnfst15 variants in ankylosing spondylitis,” International Journal of Clinical and Experimental Pathology, vol. 8, pp. 15210–15215, 2015. View at Google Scholar
  6. R. Max, H. M. Lorenz, and F. Mackensen, “Ocular involvment in spondyloarthropathies: HLA B27 associated uveitis,” Zeitschrift für Rheumatologie, vol. 69, no. 5, pp. 397–402, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Ou, “Anthrax toxin receptor 2 gene (ANTXR2) rs4333130 is associated with ankylosing spondylitis,” International Journal of Clinical and Experimental Medicine, vol. 8, no. 5, pp. 7679–7683, 2015. View at Google Scholar · View at Scopus
  8. W. Chai, Z. Lian, C. Chen, J. Liu, L. L. Shi, and Y. Wang, “JARID1A, JMY, and PTGER4 Polymorphisms Are Related to Ankylosing Spondylitis in Chinese Han Patients: A Case-Control Study,” PLoS ONE, vol. 8, no. 9, Article ID e74794, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. K. X. Wang and D. T. Denhardt, “Osteopontin: role in immune regulation and stress responses,” Cytokine & Growth Factor Reviews, vol. 19, no. 5-6, pp. 333–345, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Murugaiyan, A. Mittal, and H. L. Weiner, “Increased osteopontin expression in dendritic cells amplifies IL-17 production by CD4+ T cells in experimental autoimmune encephalomyelitis and in multiple sclerosis,” The Journal of Immunology, vol. 181, no. 11, pp. 7480–7488, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Giacopelli, R. Marciano, A. Pistorio et al., “Polymorphisms in the osteopontin promoter affect its transcriptional activity,” Physiological Genomics, vol. 20, pp. 87–96, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. C.-C. Liu, S.-P. Huang, L.-Y. Tsai et al., “The impact of osteopontin promoter polymorphisms on the risk of calcium urolithiasis,” Clinica Chimica Acta, vol. 411, no. 9-10, pp. 739–743, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Hendig, M. Arndt, C. Szliska, K. Kleesiek, and C. Götting, “SPPI promoter polymorphisms: Identification of the first modifier gene for pseudoxanthoma elasticum,” Clinical Chemistry, vol. 53, no. 5, pp. 829–836, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Lv, Y. Li, J. Xu et al., “Association of SPP1 promoter variants with hip osteoarthritis susceptibility in Chinese population,” Gene, vol. 564, no. 1, pp. 9–13, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Liu, C. He, Q. Yuan, Z. Wang, C. Xing, and Y. Yuan, “Association between promoter polymorphisms of OPN gene and cancer risk: A meta-analysis,” OncoTargets and Therapy, vol. 9, pp. 87–97, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. B. Cheema, S. Iyengar, R. Sharma, H. Kohli, A. Bhansali, and M. Khullar, “Association between Osteopontin Promoter Gene Polymorphisms and Haplotypes with Risk of Diabetic Nephropathy,” Journal of Clinical Medicine, vol. 4, no. 6, pp. 1281–1292, 2015. View at Publisher · View at Google Scholar
  17. J. C.-C. Wei, R.-H. Wong, J.-H. Huang et al., “Evaluation of internal consistency and re-test reliability of Bath ankylosing spondylitis indices in a large cohort of adult and juvenile spondylitis patients in Taiwan,” Clinical Rheumatology, vol. 26, no. 10, pp. 1685–1691, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. S. T. Choi, J. H. Kim, E.-J. Kang et al., “Osteopontin might be involved in bone remodelling rather than in inflammation in ankylosing spondylitis,” Rheumatology, vol. 47, no. 12, pp. 1775–1779, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. A. P. Xu, J. Bai, J. Lu, Y. Y. Liang, J. G. Li, D. Y. Lai et al., “Osteopontin gene polymorphism in association with systemic lupus erythematosus in Chinese patients,” Chinese Medical Journal, vol. 120, pp. 2124–2128, 2007. View at Google Scholar
  20. J. Glas, J. Seiderer, C. Bayrle et al., “The role of osteopontin (OPN/SPP1) haplotypes in the susceptibility to Crohn's disease,” PLoS ONE, vol. 6, no. 12, Article ID e29309, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Urcelay, A. Martínez, A. Mas-Fontao et al., “Osteopontin gene polymorphisms in spanish patients with rheumatoid arthritis,” The Journal of Rheumatology, vol. 32, no. 3, pp. 405–409, 2005. View at Google Scholar · View at Scopus
  22. S. Salimi, M. Noora, S. Nabizadeh et al., “Association of the osteopontin rs1126616 polymorphism and a higher serum osteopontin level with lupus nephritis,” Biomedical Reports, vol. 4, no. 3, pp. 355–360, 2016. View at Publisher · View at Google Scholar
  23. N. Yamamoto, F. Sakai, S. Kon et al., “Essential role of the cryptic epitope SLAYGLR within osteopontin in a murine model of rheumatoid arthritis,” The Journal of Clinical Investigation, vol. 112, no. 2, pp. 181–188, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Tamura, M. Shingai, N. Aso, T. Hazuku, and M. Nasu, “Osteopontin is released from the heart into the coronary circulation in patients with a previous anterior wall myocardial infarction,” Circulation Journal, vol. 67, no. 9, pp. 742–744, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Xie, M. Sakatsume, S. Nishi, I. Narita, M. Arakawa, and F. Gejyo, “Expression, roles, receptors, and regulation of osteopontin in the kidney,” Kidney International, vol. 60, no. 5, pp. 1645–1657, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. D. T. Denhardt and S. R. Rittling, “Osteopontin function in pathology: Lessons from osteopontin-deficient mice,” Experimental Nephrology, vol. 7, no. 2, pp. 103–113, 1999. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Mi, K. Ren, F. Dai, L. Zhu, and N. Feng, “OPN gene polymorphisms, rs17524488 GG/G, rs11730582 T/C, and rs9138 C/A, and cancer risk in a Chinese population,” Scientific Reports, vol. 5, Article ID 14164, 2015. View at Publisher · View at Google Scholar · View at Scopus